Literature DB >> 14592912

A simple manual muscle test for myasthenia gravis: validation and comparison with the QMG score.

Donald B Sanders1, Bernadette Tucker-Lipscomb, Janice M Massey.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14592912     DOI： 10.1196/annals.1254.057

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  22 in total

1.  Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial.

Authors:  Michael Benatar; Michael P Mcdermott; Donald B Sanders; Gil I Wolfe; Richard J Barohn; Richard J Nowak; Michael Hehir; Vern Juel; Hans Katzberg; Rabi Tawil
Journal:  Muscle Nerve       Date:  2016-01-27       Impact factor: 3.217

2.  The MG Composite: A valid and reliable outcome measure for myasthenia gravis.

Authors:  Ted M Burns; Mark Conaway; Donald B Sanders
Journal:  Neurology       Date:  2010-05-04       Impact factor: 9.910

3.  Circulating microRNA plasma profile in MuSK+ myasthenia gravis.

Authors:  Liis Sabre; Jeffrey T Guptill; Melissa Russo; Vern C Juel; Janice M Massey; James F Howard; Lisa D Hobson-Webb; Anna Rostedt Punga
Journal:  J Neuroimmunol       Date:  2018-10-06       Impact factor: 3.478

4.  Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment.

Authors:  John S Yi; Emily C Decroos; Donald B Sanders; Kent J Weinhold; Jeffrey T Guptill
Journal:  Muscle Nerve       Date:  2013-10-07       Impact factor: 3.217

5.  Granulocyte macrophage colony-stimulating factor treatment of a patient in myasthenic crisis: effects on regulatory T cells.

Authors:  Julie Rowin; Muthusamy Thiruppathi; Ebinehita Arhebamen; Jianrong Sheng; Bellur S Prabhakar; Matthew N Meriggioli
Journal:  Muscle Nerve       Date:  2012-09       Impact factor: 3.217

6.  Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis.

Authors:  Jeffrey T Guptill; Vern C Juel; Janice M Massey; Amanda C Anderson; Manisha Chopra; John S Yi; Ehsanollah Esfandiari; Tim Buchanan; Bryan Smith; Paul Atherfold; Emma Jones; James F Howard
Journal:  Autoimmunity       Date:  2016-08-11       Impact factor: 2.815

7.  Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low/-) T cells in patients with myasthenia gravis.

Authors:  Muthusamy Thiruppathi; Julie Rowin; Balaji Ganesh; Jian Rong Sheng; Bellur S Prabhakar; Matthew N Meriggioli
Journal:  Clin Immunol       Date:  2012-10-07       Impact factor: 3.969

8.  Inhibition of the transcription factor ROR-γ reduces pathogenic Th17 cells in acetylcholine receptor antibody positive myasthenia gravis.

Authors:  John S Yi; Melissa A Russo; Shruti Raja; Janice M Massey; Vern C Juel; Jay Shin; Lisa D Hobson-Webb; Karissa Gable; Jeffrey T Guptill
Journal:  Exp Neurol       Date:  2019-12-12       Impact factor: 5.330

9.  Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.

Authors:  J S Yi; A Guidon; S Sparks; R Osborne; V C Juel; J M Massey; D B Sanders; K J Weinhold; J T Guptill
Journal:  J Autoimmun       Date:  2013-12-28       Impact factor: 7.094

10.  A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis.

Authors:  Mamatha Pasnoor; Jianghua He; Laura Herbelin; Ted M Burns; Sharon Nations; Vera Bril; Annabel K Wang; Bakri H Elsheikh; John T Kissel; David Saperstein; J Aziz Shaibani; Carlayne Jackson; Andrea Swenson; James F Howard; Namita Goyal; William David; Matthew Wicklund; Michael Pulley; Mara Becker; Tahseen Mozaffar; Michael Benatar; Robert Pazcuzzi; Ericka Simpson; Jeffrey Rosenfeld; Mazen M Dimachkie; Jeffrey M Statland; Richard J Barohn
Journal:  Neurology       Date:  2016-06-15       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.